MeSH Review:
Penile Induration
- Isolation and characterization of collagen in Peyronie's disease. Somers, K.D., Sismour, E.N., Wright, G.L., Devine, C.J., Gilbert, D.A., Horton, C.E. J. Urol. (1989)
- The genetic and bacteriological aspects of Peyronie's disease. Ralph, D.J., Schwartz, G., Moore, W., Pryor, J.P., Ebringer, A., Bottazzo, G.F. J. Urol. (1997)
- Study of the changes in collagen of the tunica albuginea in venogenic impotence and Peyronie's disease. Chiang, P.H., Chiang, C.P., Shen, M.R., Huang, C.H., Wang, C.J., Huang, I.Y., Shieh, T.Y. Eur. Urol. (1992)
- Tissue engineering in urology: where are we going? Metwalli, A.R., Colvert, J.R., Kropp, B.P. Current urology reports. (2003)
- Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. Prieto Castro, R.M., Leva Vallejo, M.E., Regueiro Lopez, J.C., Anglada Curado, F.J., Alvarez Kindelan, J., Requena Tapia, M.J. BJU international. (2003)
- The role of colour Doppler imaging in the management of Peyronie's disease. Ahmed, M., Chilton, C.P., Munson, K.W., Williams, J.H., Pallan, J.H., Turner, G. British journal of urology. (1998)
- Peyronie's disease in association with metoprolol. Yudkin, J.S. Lancet (1977)
- Propranolol and Peyronie's disease. Wallis, A.A., Bell, R., Sutherland, P.W. Lancet (1977)
- A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. Di Stasi, S.M., Giannantoni, A., Stephen, R.L., Capelli, G., Giurioli, A., Jannini, E.A., Vespasiani, G. J. Urol. (2004)
- Experience with intraplaque injection of verapamil for Peyronie's disease. Levine, L.A., Goldman, K.E., Greenfield, J.M. J. Urol. (2002)
- Results of radiotherapy and vitamin E in the treatment of Peyronie's disease. Rodrigues, C.I., Njo, K.H., Karim, A.B. Int. J. Radiat. Oncol. Biol. Phys. (1995)
- Tamoxifen versus placebo in the treatment of Peyronie's disease. Teloken, C., Rhoden, E.L., Grazziotin, T.M., Ros, C.T., Sogari, P.R., Souto, C.A. J. Urol. (1999)
- Treatment of Peyronie's disease with intralesional verapamil injection. Levine, L.A. J. Urol. (1997)
- Penile vascular assessment using color duplex sonography in men with Peyronie's disease. Levine, L.A., Coogan, C.L. J. Urol. (1996)
- Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease. Hauck, E.W., Hauptmann, A., Schmelz, H.U., Bein, G., Weidner, W., Hackstein, H. J. Urol. (2003)
- Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy. Hamilton, R.G., Mintz, G.R., Gelbard, M.K. J. Urol. (1986)
- HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis? Rompel, R., Weidner, W., Mueller-Eckhardt, G. Tissue Antigens (1991)
- Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease. Lin, C.S., Lin, G., Wang, Z., Maddah, S.A., Lue, T.F. Biochem. Biophys. Res. Commun. (2002)
- Wogonin suppresses cellular proliferation and expression of monocyte chemoattractant protein 1 in Peyronie's plaque-derived cells. Wang, Z., Lin, G., Lue, T.F., Lin, C.S. BJU international. (2003)
- The immunological features of Peyronie's disease. Ralph, D.J., Mirakian, R., Pryor, J.P., Bottazzo, G.F. J. Urol. (1996)
- Anatomy and pathophysiology of Peyronie's disease and congenital deviation of the penis. Schubert, G.E. Urologia internationalis. (1991)
- Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Duncan, M.R., Berman, B., Nseyo, U.O. Scandinavian journal of urology and nephrology. (1991)
- Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. El-Sakka, A.I., Hassoba, H.M., Pillarisetty, R.J., Dahiya, R., Lue, T.F. J. Urol. (1997)
- An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. El-Sakka, A.I., Hassoba, H.M., Chui, R.M., Bhatnagar, R.S., Dahiya, R., Lue, T.F. J. Urol. (1997)
- HLA-A and B antigens in patients with Peyronie disease. Deguchi, T., Maeda, S., Sakai, S., Kuriyama, M., Kawada, Y., Nishiura, T. Urology (1984)
- Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque. Davila, H.H., Magee, T.R., Zuniga, F.I., Rajfer, J., Gonzalez-Cadavid, N.F. Urology (2005)
- Iontophoresis for treatment of Peyronie's disease. Riedl, C.R., Plas, E., Engelhardt, P., Daha, K., Pflüger, H. J. Urol. (2000)
- A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease. Ahuja, S., Bivalacqua, T.J., Case, J., Vincent, M., Sikka, S.C., Hellstrom, W.J. J. Androl. (1999)
- Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Weidner, W., Hauck, E.W., Schnitker, J. Eur. Urol. (2005)
- Penile prosthetic surgery for Peyronie's disease: defining the need for intraoperative adjuvant maneuvers. Mulhall, J., Ahmed, A., Anderson, M. The journal of sexual medicine. (2004)